For all the progress made in shifting the U.S. healthcare system toward value-based care, one of the most powerful levers for improving outcomes and reducing costs remains underused: medications. By: Yoona Kim, PharmD, PhD, Co-Founder and CEO of Arine A version of this article was originally published in Becker’s Payer Issues on November 3, 2025.